BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Combat Medical Systems Buyout of Z-Medica, LLC Ushers in New Growth


6/27/2012 10:00:37 AM

FAYETTEVILLE, N.C., June 27, 2012 /PRNewswire/ -- Combat Medical Systems (CMS) extended its distribution agreement for Combat Gauze™, the Department of Defense (DoD) approved hemostatic, as a part of its buyout of former partner Z-Medica Corporation's ownership interest in the company effective June 21, 2012.

CMS, a leading distributor and developer of innovative medical solutions that simplify tactical medicine, will remain the exclusive government distributor of the Combat Gauze line through 2014.

To date, Combat Gauze has been fielded to every service member in the DoD. It is authorized in every Individual First Aid Kit (IFAK), Combat Life Saver and medic/corpsman medical bag.

According to a recent DoD Tactical Combat Casualty Care (TCCC) survey, in 1,895 documented battlefield uses of Combat Gauze, 90.7 percent of respondents agreed/strongly agreed that Combat Gauze was "effective at stopping severe external bleeding."

"CMS and Z-Medica worked closely to field Combat Gauze, one of our first service-wide successes," said Corey Russ, president and founder of CMS. The development of Combat Gauze offers the medic a simple, cost-effective hemostatic product to treat severe external bleeding, especially in areas where a tourniquet cannot be applied. "The buyout will let CMS further focus on being a veteran-owned, DoD medical solutions provider."

The buyout brings about a new phase of growth that will allow CMS to quickly develop new product lines and further enhance its relationship with DoD and law enforcement agencies.

"As we expand our reach around the world, all our efforts are, always have been, to simplify tactical medicine and deliver our products to our nation's warfighters and first responders," Russ said.

Combat Medical Systems, founded in 2008, is headquartered in Fayetteville, NC.

www.combatmedicalsystems.com.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES